Review article: hyperlipidaemia and cardiovascular risk

Abstract

SUMMARYHyperlipidaemia represents a determinant for the development of atherosclerosis and an important risk factor for cardiovascular disease, particularly in the context of the insulin resistance syndrome. This is characterized by alterations in the profile of plasma lipoprotein including high triglyceride levels, low high-density lipoprotein cholesterol concentrations and the appearance of qualitatively modified, small-dense low-density lipoproteins. Many charts and algorithms have been developed to estimate the entity of coronary and cardiovascular risk as related to dyslipidaemia, on the basis of additional individual risk factors and conditions: most include age and gender, smoking status, hypertension and diabetes. They should preferably be utilized in consistent patient populations, in terms of geographical areas and general risk profile. Pharmacological treatment of dyslipidaemia, in particular with statin drugs, was shown to greatly improve cardiovascular morbidity and mortality. A body of evidence also underlines the need for a multidisciplinary approach, integrating non-pharmacological lifestyle and diet interventions, as well as treatment of concomitant diseases (hypertension and diabetes).

Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review

“…Hyperlipidemia plays a key role in the development of atherosclerosis, and is a vital risk factor for cardiovascular diseases, which can be characterized by changes in the profile of serum lipids, including high triglyceride (TG) level, high cholesterol level, and low HDL-C level [43]. Treatment of male hamsters with mixed extracts of green tea, cocoa, coffee, and garcinia for 6 weeks was found to be effective in lowering serum TG, total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and hepatic TG and cholesterol in a dose-dependent manner [44].…”

Burnout and Vigor as Predictors of the Incidence of Hyperlipidemia among Healthy Employees

“…The current study focuses on the effects of job‐related burnout and vigor on the incidence of hyperlipidemia among healthy employees followed up for about 27 months. We focused on hyperlipidemia because it is one of the major causes of atherosclerosis, a precursor of coronary heart disease (Bertolotti, Maurantonio, Gabbi, Anzivino, & Carulli, 2005; Bhatnagar, Soran, & Durrington, 2008). Hyperlipidemia, characterised by abnormal alterations in the profile of plasma lipoprotein including high triglyceride levels, low high‐density and high low‐density lipoprotein cholesterol, is now routinely treated primarily by medicines such as the family of statins—representing the best‐selling drug world‐wide—prescribed by family physicians (Shojania et al., 2010).…”

Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

“…In addition, many cases of chronic kidney disease are a result of the atherosclerotic process occurring in both small and large blood vessels, such that cardiovascular disease resulting from this process is the most common cause of death of patients on renal replacement therapies 2, 3. While hypertension and hyperlipidemia have been known for decades to be causative factors in the development of arterial plaque 4, data demonstrating the occurrence of severe atherosclerosis in a subset of patients without these risk factors suggest that inflammatory mediators are of prime importance in the pathogenesis of these lesions5. Thus, novel anti-hypertensive therapies are being sought which target blood pressure as well as inflammation 6.…”